Cargando…
N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
N-Myristoyltransferase (NMT) catalyses the attachment of the 14-carbon saturated fatty acid, myristate, to the amino-terminal glycine residue of a subset of eukaryotic proteins that function in multiple cellular processes, including vesicular protein trafficking and signal transduction. In these pat...
Autores principales: | Brannigan, James A., Smith, Barbara A., Yu, Zhiyong, Brzozowski, Andrzej M., Hodgkinson, Michael R., Maroof, Asher, Price, Helen P., Meier, Franziska, Leatherbarrow, Robin J., Tate, Edward W., Smith, Deborah F., Wilkinson, Anthony J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829124/ https://www.ncbi.nlm.nih.gov/pubmed/20036251 http://dx.doi.org/10.1016/j.jmb.2009.12.032 |
Ejemplares similares
-
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
por: Rackham, Mark D., et al.
Publicado: (2015) -
Diverse modes of binding in structures of Leishmania major
N-myristoyltransferase with selective inhibitors
por: Brannigan, James A., et al.
Publicado: (2014) -
Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites
por: Olaleye, Tayo O., et al.
Publicado: (2014) -
Novel Thienopyrimidine
Inhibitors of Leishmania
N-Myristoyltransferase with On-Target Activity in Intracellular
Amastigotes
por: Bell, Andrew S., et al.
Publicado: (2020) -
Structure-Based Design of
Potent and Selective LeishmaniaN-Myristoyltransferase
Inhibitors
por: Hutton, Jennie A., et al.
Publicado: (2014)